160 related articles for article (PubMed ID: 6432040)
1. Kinetics of polymerization of a fluoresceinated derivative of complement protein C9 by the membrane-bound complex of complement proteins C5b-8.
Sims PJ; Wiedmer T
Biochemistry; 1984 Jul; 23(14):3260-7. PubMed ID: 6432040
[TBL] [Abstract][Full Text] [Related]
2. Complement protein C9 labeled with fluorescein isothiocyanate can be used to monitor C9 polymerization and formation of the cytolytic membrane lesion.
Sims PJ
Biochemistry; 1984 Jul; 23(14):3248-60. PubMed ID: 6432039
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization.
McDonald JF; Nelsestuen GL
Biochemistry; 1997 Jun; 36(24):7464-73. PubMed ID: 9200695
[TBL] [Abstract][Full Text] [Related]
4. Fluid-phase assembly of the membrane attack complex of complement.
Silversmith RE; Nelsestuen GL
Biochemistry; 1986 Feb; 25(4):841-51. PubMed ID: 3964648
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence resonance energy transfer study of the associative state of membrane-bound complexes of complement proteins C5b-8.
Cheng KH; Wiedmer T; Sims PJ
J Immunol; 1985 Jul; 135(1):459-64. PubMed ID: 3923109
[TBL] [Abstract][Full Text] [Related]
6. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
Sims PJ
Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
[TBL] [Abstract][Full Text] [Related]
7. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
Bhakdi S; Tranum-Jensen J
J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
Rosenfeld SI; Packman CH; Leddy JP
J Clin Invest; 1983 Apr; 71(4):795-808. PubMed ID: 6403580
[TBL] [Abstract][Full Text] [Related]
9. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
Stewart JL; Monahan JB; Brickner A; Sodetz JM
Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
[TBL] [Abstract][Full Text] [Related]
10. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.
Tschopp J; Podack ER; Müller-Eberhard HJ
J Immunol; 1985 Jan; 134(1):495-9. PubMed ID: 3964819
[TBL] [Abstract][Full Text] [Related]
11. Assembly of the membrane attack complex of complement on small unilamellar phospholipid vesicles.
Silversmith RE; Nelsestuen GL
Biochemistry; 1986 Feb; 25(4):852-60. PubMed ID: 3964649
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
13. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
14. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
Hu VW; Shin ML
J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
[TBL] [Abstract][Full Text] [Related]
15. Homologous restriction factor: effect on complement C8 and C9 uptake and lysis.
Zalman LS; Müller-Eberhard H
Mol Immunol; 1994 Mar; 31(4):301-5. PubMed ID: 8139583
[TBL] [Abstract][Full Text] [Related]
16. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
Meri S; Morgan BP; Davies A; Daniels RH; Olavesen MG; Waldmann H; Lachmann PJ
Immunology; 1990 Sep; 71(1):1-9. PubMed ID: 1698710
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
Podack ER; Preissner KT; Müller-Eberhard HJ
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
[TBL] [Abstract][Full Text] [Related]
18. The relationship between channel size and the number of C9 molecules in the C5b-9 complex.
Ramm LE; Whitlow MB; Mayer MM
J Immunol; 1985 Apr; 134(4):2594-9. PubMed ID: 2579147
[TBL] [Abstract][Full Text] [Related]
19. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
[TBL] [Abstract][Full Text] [Related]
20. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
Podack ER; Tschoop J; Müller-Eberhard HJ
J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]